ELIZABETH HAGGERTY: Open Payments
NPI 1902553266 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 169 payments from 19 companies in 2025. Trend: 2023 $1,922 · 2024 $3,501 · 2025 $3,367
Food & beverage: $3,307Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $1,297 |
| Janssen Biotech, Inc. | 18 | $441 |
| Aimmune Therapeutics, Inc. | 14 | $338 |
| QOL Medical, LLC | 9 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $177 |
| GENZYME CORPORATION | 8 | $157 |
| Celltrion USA Inc. | 5 | $110 |
| Lilly USA, LLC | 5 | $99 |
| Gilead Sciences, Inc. | 4 | $90 |
| PFIZER INC. | 4 | $84 |
Products named: RINVOQ, SKYRIZI, TREMFYA, ZENPEP, Sucraid, XIFAXAN, CREON, DUPIXENT.
Industry payments across TN — which companies pay providers there.
